Stay updated on Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:00:49.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and notes that NIH content may use both “Super Intelligence” and “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T14:33:16.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:26:03.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:24:04.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with minimal header/footer/navigation, replacing the previous study content and documents.*
    Difference
    20%
    Check dated 2026-09-19T20:46:57.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.5 to v3.6.6, signaling a newer edition of the ClinicalTrials.gov entry. This appears to be an administrative update rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-08-29T21:47:06.000Z thumbnail image

Stay in the know with updates to Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.